Aims Testosterone deficiency (TD) is associated with increased morbidity and mortality in heart failure with reduced ejection fraction (HFrEF). However, data in women are scanty. The aim of this study was to investigate the prognostic impact of TD on women with HFrEF.Methods Among 480 patients prospectively enrolled in the T.O.S.CA. (Terapia Ormonale Scompenso CArdiaco) registry, a prospective, multicentre, nationwide, observational study, 94 women were included in the current analysis. The TD was defined as serum testosterone levels lower than 25 ng/dl. Data regarding clinical status, echocardiography, exercise performance, cardiovascular hospitalization, and survival after an average follow-up of 36 months were analysed.Results Thirty patients (31.9%) displayed TD. TD was associated with lower tricuspid annular plane excursion (TAPSE) to pulmonary arterial systolic pressure PASP ratio (TAPSE/PASP) (P = 0.008), peak oxygen consumption (VO2 peak) (P = 0.03) and estimated glomerular filtration rate (P < 0.001). TD was an independent predictor of the combined endpoint of all-cause mortality/cardiovascular hospitalization (HR: 10.45; 95% CI: 3.54-17.01; P = 0.001), all-cause mortality (HR: 8.33; 95%: 5.36-15.11; P = 0.039), and cardiovascular hospitalization (HR: 2.41; 95% CI: 1.13-4.50; P = 0.02).Conclusions One-third of women with HFrEF displays TD that impacts remarkably on their morbidity and mortality. TD is associated with a worse clinical profile including exercise capacity, right ventricular-pulmonary arterial coupling, and renal function. These findings lend support to an accurate profiling of women with HF, a problem often overlooked in clinical trials.

Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry / Marra, Alberto M; D'Assante, Roberta; Salzano, Andrea; Iacoviello, Massimo; Triggiani, Vincenzo; Rengo, Giuseppe; Limongelli, Giuseppe; Masarone, Daniele; Perticone, Maria; Cimellaro, Antonio; Perrone Filardi, Pasquale; Paolillo, Stefania; Gargiulo, Paola; Mancini, Antonio; Volterrani, Maurizio; Vriz, Olga; Castello, Roberto; Passantino, Andrea; Campo, Michela; Modesti, Pietro A; De Giorgi, Alfredo; Arcopinto, Michele; D'Agostino, Anna; Raparelli, Valeria; Isidori, Andrea M; Valente, Valeria; Giardino, Federica; Crisci, Giulia; Sciacqua, Angela; Savoia, Marcella; Suzuki, Toru; Bossone, Eduardo; Cittadini, Antonio. - In: ESC HEART FAILURE. - ISSN 2055-5822. - STAMPA. - (2022), pp. 1-8. [10.1002/ehf2.14117]

Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry

Modesti, Pietro A
Membro del Collaboration Group
;
2022

Abstract

Aims Testosterone deficiency (TD) is associated with increased morbidity and mortality in heart failure with reduced ejection fraction (HFrEF). However, data in women are scanty. The aim of this study was to investigate the prognostic impact of TD on women with HFrEF.Methods Among 480 patients prospectively enrolled in the T.O.S.CA. (Terapia Ormonale Scompenso CArdiaco) registry, a prospective, multicentre, nationwide, observational study, 94 women were included in the current analysis. The TD was defined as serum testosterone levels lower than 25 ng/dl. Data regarding clinical status, echocardiography, exercise performance, cardiovascular hospitalization, and survival after an average follow-up of 36 months were analysed.Results Thirty patients (31.9%) displayed TD. TD was associated with lower tricuspid annular plane excursion (TAPSE) to pulmonary arterial systolic pressure PASP ratio (TAPSE/PASP) (P = 0.008), peak oxygen consumption (VO2 peak) (P = 0.03) and estimated glomerular filtration rate (P < 0.001). TD was an independent predictor of the combined endpoint of all-cause mortality/cardiovascular hospitalization (HR: 10.45; 95% CI: 3.54-17.01; P = 0.001), all-cause mortality (HR: 8.33; 95%: 5.36-15.11; P = 0.039), and cardiovascular hospitalization (HR: 2.41; 95% CI: 1.13-4.50; P = 0.02).Conclusions One-third of women with HFrEF displays TD that impacts remarkably on their morbidity and mortality. TD is associated with a worse clinical profile including exercise capacity, right ventricular-pulmonary arterial coupling, and renal function. These findings lend support to an accurate profiling of women with HF, a problem often overlooked in clinical trials.
1
8
Marra, Alberto M; D'Assante, Roberta; Salzano, Andrea; Iacoviello, Massimo; Triggiani, Vincenzo; Rengo, Giuseppe; Limongelli, Giuseppe; Masarone, Daniele; Perticone, Maria; Cimellaro, Antonio; Perrone Filardi, Pasquale; Paolillo, Stefania; Gargiulo, Paola; Mancini, Antonio; Volterrani, Maurizio; Vriz, Olga; Castello, Roberto; Passantino, Andrea; Campo, Michela; Modesti, Pietro A; De Giorgi, Alfredo; Arcopinto, Michele; D'Agostino, Anna; Raparelli, Valeria; Isidori, Andrea M; Valente, Valeria; Giardino, Federica; Crisci, Giulia; Sciacqua, Angela; Savoia, Marcella; Suzuki, Toru; Bossone, Eduardo; Cittadini, Antonio
File in questo prodotto:
File Dimensione Formato  
ESC Heart Failure - 2022 - Marra - Testosterone deficiency independently predicts mortality in women with HFrEF insights.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: DRM non definito
Dimensione 233.99 kB
Formato Adobe PDF
233.99 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/1288230
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact